Expand AUTL Menu
AUTL MENU

AUTL Stock Summary and Trading Ideas (Autolus Therapeutics PLC - American Depositary Shares | NASDAQ:AUTL)

Charts for Today's Stock Price and Implied Volatility in Autolus Therapeutics PLC - American Depositary Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AUTL by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Autolus Therapeutics PLC - American Depositary Shares (AUTL) Frequently Asked Questions

What does Autolus Therapeutics PLC - American Depositary Shares do?

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

What symbol and exchange does Autolus Therapeutics PLC - American Depositary Shares shares trade?

Autolus Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AUTL.

What is Autolus Therapeutics PLC - American Depositary Shares stock price doing today?

As of August 6, 2026, AUTL stock price climbed to $2.00 with 3,741,041 million shares trading.

What is Autolus Therapeutics PLC - American Depositary Shares's Beta?

AUTL has a beta of 2.26, meaning it tends to be more sensitive to market movements. AUTL has a correlation of 0.16 to the broad based SPY ETF.

How much is Autolus Therapeutics PLC - American Depositary Shares worth?

AUTL has a market cap of $531.85 million. This is considered a Small Cap stock.

How much money does Autolus Therapeutics PLC - American Depositary Shares make?

Last quarter Autolus Therapeutics PLC - American Depositary Shares reported $26 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $57,912 and met earnings estimates .

What is the highest and lowest price Autolus Therapeutics PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, AUTL traded as high as $7.45 and as low as $1.11.

What are the top ETFs holding Autolus Therapeutics PLC - American Depositary Shares?

The top ETF exchange traded funds that AUTL belongs to (by Net Assets): IBB, CANC, GWX, QQQS, APIE.

Is Autolus Therapeutics PLC - American Depositary Shares (AUTL) a good investment?

AUTL has underperformed the market in the last year with a return of -15.6%, while SPY returned +23.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AUTL shares. However, AUTL has outperformed the market in the last 3 month and 2 week periods, returning +22.0% and +38.9%, while SPY returned +6.5% and +2.8%, respectively. This indicates AUTL has been having a stronger performance recently.

What are the support and resistance levels for Autolus Therapeutics PLC - American Depositary Shares (AUTL)?

AUTL support price is $1.81 and resistance is $1.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUTL shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes